Shares lower as CBA drops 2pc; ACCC mulls penalties for Telstra; Barrenjoey upgrades MinRes; $A lingers near US64¢; Domain, Nine leap on CoStar bid, REA slumps.

Shares of Telix Pharmaceuticals surged to a record high on Friday after the company forecast annual bumper revenue, while its full-year earnings for 2024 soared more than ninefold.

Indian benchmark indices ended in the red on Friday, extending their losing streak to a third consecutive week. The decline ...

This week’s Bulls N’ Bears ASX Runner of the Week is… West Cobar. Its share price shot up on outstanding antimony results from its Bulla Park project in NSW.

Cosette Pharmaceuticals, Inc., a U.S.-based, fully integrated, pharmaceutical company, announced today that it has entered into a definitive agreement ...

For the past three years, current CEO and 35 year veteran of Macquarie Group (ASX: MQG) ranked as the highest paid CEO on the ...

Mexican fast-food chain Guzman y Gomez on Friday reported first-half underlying earnings that missed estimates as declining ...

It's been a wild ride for investors so far this February earnings season. With only five trading days of the month to go, the S&P/ASX 200 Index (ASX: XJO) has fallen by a hefty 2.77% since the end of ...

(Reuters) - Australia-listed Mexican-themed fast-food chain Guzman y Gomez said on Friday its first-half earnings nearly doubled, putting it firmly on track to surpass its fiscal 2025 profit forecast ...

What is ASX reporting season? Reporting or earnings season refers to the time of year when most publicly listed companies release their financial results to the market and announce the dividends ...

Australia’s S&P/ASX 200 looks set to edge higher at the start of the week’s final trading session, paring its hefty recent losses.

Shares have tumbled over two whipsaw trading sessions to mean this could be an opportunity to get on the planet's hottest ...